BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8474092)

  • 21. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan.
    Kotajima L; Aotsuka S; Sumiya M; Yokohari R; Tojo T; Kasukawa R
    J Rheumatol; 1996 Jun; 23(6):1088-94. PubMed ID: 8782145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone resorption in systemic sclerosis (scleroderma).
    Choy GW; Al-Emadi S; Lee P
    J Rheumatol; 2004 Oct; 31(10):2086-7. PubMed ID: 15468382
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of electromyographic pictures of various forms of circumscribed scleroderma.
    Hausmanowa-Petrusewicz I; Koźmińska A
    Pol Med J; 1966; 5(3):693-9. PubMed ID: 5920284
    [No Abstract]   [Full Text] [Related]  

  • 24. Often forgotten manifestations of systemic sclerosis.
    Shah AA; Wigley FM
    Rheum Dis Clin North Am; 2008 Feb; 34(1):221-38; ix. PubMed ID: 18329542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion.
    Slobodin G; Rosner I; Rozenbaum M; Naschitz JE; Zuckerman E; Yeshurun D
    Rheumatol Int; 2002 Aug; 22(4):170-2. PubMed ID: 12172958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in the gastrointestinal system of children with inflammatory systemic connective tissue diseases].
    Rutkowska-Sak L; Legatowicz-Koprowska M; Ryzko J; Socha J
    Pediatr Pol; 1995 Mar; 70(3):235-41. PubMed ID: 8657492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial lung disease as the first manifestation of systemic sclerosis.
    van der Kamp R; Tak PP; Jansen HM; Bresser P
    Neth J Med; 2007 Nov; 65(10):390-4. PubMed ID: 18057462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Takehara K; Sato S
    Ann Rheum Dis; 2004 May; 63(5):583-7. PubMed ID: 15082492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of heart rhythm variability and arrhythmia in children with systemic and localized scleroderma.
    Wozniak J; Dabrowski R; Luczak D; Kwiatkowska M; Musiej-Nowakowska E; Kowalik I; Szwed H
    J Rheumatol; 2009 Jan; 36(1):191-6. PubMed ID: 19040309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
    Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet contributions to the pathogenesis of systemic sclerosis.
    Postlethwaite AE; Chiang TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):574-9. PubMed ID: 17917538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients.
    Dziankowska-Bartkowiak B; Waszczykowska E; Zalewska A; Sysa-Jedrzejowska A
    Mediators Inflamm; 2005 Aug; 2005(3):144-9. PubMed ID: 16106100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Scleroderma with anomalies of the thyroid function. 7 cases].
    Ghayad E; Tohme A; Haddad F; Haddad C; Choueiry R
    Ann Med Interne (Paris); 1997; 148(4):307-10. PubMed ID: 9515097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathogenesis of scleroderma].
    Marie I
    Rev Prat; 2002 Nov; 52(17):1873-81. PubMed ID: 12532863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heart in systemic sclerosis.
    LeRoy EC
    N Engl J Med; 1984 Jan; 310(3):188-90. PubMed ID: 6690933
    [No Abstract]   [Full Text] [Related]  

  • 37. Bleomycin-induced scleroderma.
    Sharma SK; Handa R; Sood R; Aggarwal P; Biswas A; Kumar U; Wali JP
    J Assoc Physicians India; 2004 Jan; 52():76-7. PubMed ID: 15633728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunopathological disturbances in systemic sclerosis].
    Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
    Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation methods in patients with systemic sclerosis].
    Kuwana M; Sato S; Kondo H; Takehara K
    Ryumachi; 2002 Aug; 42(4):654-65. PubMed ID: 12355860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.